Xencor, Inc. (XNCR)
12.69
+0.76
(+6.37%)
USD |
NASDAQ |
May 01, 16:00
12.68
0.00 (0.00%)
After-Hours: 20:00
Xencor Shareholders Equity (Quarterly) : 635.59M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 637.99M |
| Rigel Pharmaceuticals, Inc. | 391.48M |
| Ultragenyx Pharmaceutical, Inc. | -80.00M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 875.50M |
| Total Liabilities (Quarterly) | 239.91M |
| Debt to Equity Ratio | 0.2954 |
| Current Ratio | 6.254 |
| Net Debt Paydown Yield | -1.84% |